Clinical Report: Evaluation of Serum Biomarkers to Inform Anemia Management in Individuals with Chronic Liver Disease

Overview

This study investigates the correlation between anemia-related biomarkers and disease severity in patients with chronic liver disease (CLD). Findings suggest that specific biomarkers may aid in the diagnosis and management of anemia in this population.

Background

Chronic liver disease (CLD) is a major global health issue, affecting approximately 1.5 billion individuals and leading to significant morbidity and mortality. Anemia is a common complication in CLD, affecting about 75% of patients, yet its management remains challenging due to a lack of precise diagnostic criteria and understanding of underlying mechanisms. Identifying effective biomarkers could enhance the management of anemia in these patients.

Data Highlights

Key Findings

• Anemia in CLD is closely associated with disease severity and complications.
• EPO levels correlate positively with STFR in macrocytic and normocytic anemia.
• MCV shows a positive correlation with MELD and APRI scores.
• TBIL correlates positively with FIB-4 scores.
• WBC and ferritin levels are positively correlated.
• Biomarkers are statistically significant across different anemia types and bilirubin levels.

Clinical Implications

Clinicians should consider the use of anemia-related biomarkers to better evaluate liver function and manage anemia in patients with chronic liver disease. Understanding the correlations between these biomarkers and disease severity can inform treatment strategies and improve patient outcomes.

Conclusion

This exploratory study highlights the potential of anemia-related biomarkers in managing anemia associated with chronic liver disease. Further validation in larger cohorts is necessary to establish their clinical utility.

References

1. Branched-Chain Amino Acid Granules Enhance the Structure and Function of Human Serum Albumin in Patients with Cirrhosis, Journal of Gastroenterology, 2016
2. Does the Non-Invasive Assessment of Liver Fibrosis via Serum Scores Enhance Risk Assessment in Acute Coronary Syndrome Patients?, Clinical Research in Cardiology, 2023
3. Metabolomic Analysis of Serum and Identification of Potential Biomarkers for Fibrosis Severity in Nonalcoholic Fatty Liver Disease, Journal of Gastroenterology, 2013
4. The relationship between cardiac and liver iron evaluated by MR imaging in haematological malignancies and chronic liver disease, Blood Cancer Journal, 2011
5. Management of acute variceal bleeding, PMC, 2024
6. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations, NCBI Bookshelf, 2023
7. Management of acute variceal bleeding - PMC
8. EVIDENCE AND RECOMMENDATIONS - WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations - NCBI Bookshelf
9. Clin Chem Lab Med 2024; 62(3): 373–384